Cargando…
Stromal oncostatin M cytokine promotes breast cancer progression by reprogramming the tumor microenvironment
The tumor microenvironment (TME) is reprogrammed by cancer cells and participates in all stages of tumor progression. The contribution of stromal cells to the reprogramming of the TME is not well understood. Here, we provide evidence of the role of the cytokine oncostatin M (OSM) as central node for...
Autores principales: | Araujo, Angela M., Abaurrea, Andrea, Azcoaga, Peio, López-Velazco, Joanna I., Manzano, Sara, Rodriguez, Javier, Rezola, Ricardo, Egia-Mendikute, Leire, Valdés-Mora, Fátima, Flores, Juana M., Jenkins, Liam, Pulido, Laura, Osorio-Querejeta, Iñaki, Fernández-Nogueira, Patricia, Ferrari, Nicola, Viera, Cristina, Martín-Martín, Natalia, Tzankov, Alexandar, Eppenberger-Castori, Serenella, Alvarez-Lopez, Isabel, Urruticoechea, Ander, Bragado, Paloma, Coleman, Nicholas, Palazón, Asís, Carracedo, Arkaitz, Gallego-Ortega, David, Calvo, Fernando, Isacke, Clare M., Caffarel, María M., Lawrie, Charles H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Clinical Investigation
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8970678/ https://www.ncbi.nlm.nih.gov/pubmed/35192545 http://dx.doi.org/10.1172/JCI148667 |
Ejemplares similares
-
Stromal oncostatin M cytokine promotes breast cancer progression by reprogramming the tumor microenvironment
por: Araujo, Angela M., et al.
Publicado: (2022) -
New perspectives in cancer immunotherapy: targeting IL-6 cytokine family
por: Soler, Maria Florencia, et al.
Publicado: (2023) -
Diffuse large B-cell lymphoma microenvironment displays a predominant macrophage infiltrate marked by a strong inflammatory signature
por: Serna, Leyre, et al.
Publicado: (2023) -
Oncostatin M receptor is a novel therapeutic target in cervical squamous cell carcinoma
por: Caffarel, Maria M, et al.
Publicado: (2014) -
Increased Level of Phosphorylated ShcA Measured by Chemiluminescence-Linked Immunoassay Is a Predictor of Good Prognosis in Primary Breast Cancer Expressing Low Levels of Estrogen Receptor
por: Cicenas, Jonas, et al.
Publicado: (2010)